Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17131.08 -49.10 NIFTY 5090.55 -13.00
 

Piramal Life Sciences Quarterly Results, Piramal Life Sciences Financial Statement & Accounts

Piramal Life Sciences

BSE: 532979  |  NSE: PIRLIFE  |  ISIN: INE122J01015  |  Pharmaceuticals

Notes To The Accounts
Print/Copy to Excel :
« Previous Years  

Quarterly Results of Piramal Life Sciences

------------------- in Rs. Cr. -------------------
Sep '08 Dec '08 Mar '09 Jun '09 Sep '09
Sales Turnover -- 1.76 0.52 1.73 2.55
Other Income -- -- -- -- --
Total Income -- 1.76 0.52 1.73 2.55
Total Expenses 22.38 21.54 30.59 21.77 25.94
Operating Profit -22.38 -19.78 -30.07 -20.04 -23.39
Profit On Sale Of Assets -- -- -- -- --
Profit On Sale Of Investments -- -- -- -- --
Gain/Loss On Foreign Exchange -- -- -- -- --
VRS Adjustment -- -- -- -- --
Other Extraordinary Income/Expenses -- -- -- -- --
Total Extraordinary Income/Expenses -- -- -- -- --
Tax On Extraordinary Items -- -- -- -- --
Net Extra Ordinary Income/Expenses -- -- -- -- --
Gross Profit -22.38 -19.78 -30.07 -20.04 -23.39
Interest 1.43 3.43 4.24 5.45 5.51
PBDT -23.81 -23.21 -34.31 -25.49 -28.90
Depreciation 2.47 2.52 2.50 2.52 2.68
Depreciation On Revaluation Of Assets -- -- -- -- --
PBT -26.28 -25.73 -36.81 -28.01 -31.58
Tax 0.03 0.18 0.55 0.11 -0.11
Net Profit -26.31 -25.91 -37.36 -28.12 -31.47
Prior Years Income/Expenses -- -- -- -- --
Depreciation for Previous Years Written Back/ Provided -- -- -- -- --
Dividend -- -- -- -- --
Dividend Tax -- -- -- -- --
Dividend (%) -- -- -- -- --
Earnings Per Share -- -- -- -- --
Book Value -- -- -- -- --
Equity 25.45 25.45 25.45 25.45 25.45
Reserves -- -- -- 158.21 --
Face Value 10.00 10.00 10.00 10.00 10.00
Source : Religare Technova
Explore Piramal Life connections